Latest News

Stay up to date with the latest developments in myasthenia gravis research, advocacy, and community support. Explore news, events, and policy updates to stay informed and get involved.

Browse our categories to explore stories relevant to you, and stay connected with the MG community.

All
  • All
  • About MAA News Items
  • Annual Conference News Items
  • Art With Heart News Items
  • Get Involved News Items
  • Health Professionals News Items
  • Living with MG News Items
  • MG Awareness Month News Items
  • Patient Tool Kit
  • Policy Makers News Items
  • Understanding MG News Items
MAA_CovidSurvey-300x205px_closes
SURVEY – FINAL CHANCE

SURVEY – The impact of the Coronavirus disease (COVID-19) pandemic on myasthenia gravis patients in an Australian population

MAA_CovidSurvey-300x205px
Do You Have a Myasthenic Syndrome?

SURVEY – The impact of the Coronavirus disease (COVID-19) pandemic on myasthenia gravis patients in an Australian population

MAA_CovidSurvey-300x205px
Do You Have a Myasthenic Syndrome?

SURVEY – The impact of the Coronavirus disease (COVID-19) pandemic on myasthenia gravis patients in an Australian population

PatientReportedSurveyMAAImage
Patient reported outcome survey closing soon

The Patient Reported Side-Effects Experience Survey is closing soon.

MAA Covid-19 Vaccination Announcement

An update to COVID-19 Vaccination

UPDATED – Patient Reported Outcome Survey Progress

Take part in Patient Reported Outcome Survey.

Patient Reported Outcome Survey Progress

Take part in Patient Reported Outcome Survey.

Prof. Steve Vucic talks about the Patient Reported Survey Project.

An interesting and informative podcast has been produced to discuss the latest myasthenia research project.

RITUXIMAB PBS LISTED!

Rituximab has now been listed on the Pharmaceutical Benefits Scheme.

Recommendations on the use of a 3rd Primary Dose of COVID-19 Vaccinations for People Severely Immunocompromised

Recommendations on the use of a 3rd Primary Dose of COVID-19 Vaccinations for People Severely Immunocompromised